Patients with PNH have a subset of hematopoietic stem cells that lack Glycosylphosphatidylinositol (GPI)–anchored proteins, such as the complement regulators CD55 and CD59. Here, CD59 is linked to paroxysmal nocturnal hemoglobinuria.